Department of Health, London, UK.
Lancet. 2010 Nov 27;376(9755):1846-52. doi: 10.1016/S0140-6736(10)61195-6. Epub 2010 Oct 26.
Young people (aged 0-18 years) have been disproportionately affected by pandemic influenza A H1N1 infection. We aimed to analyse paediatric mortality to inform clinical and public health policies for future influenza seasons and pandemics.
All paediatric deaths related to pandemic influenza A H1N1 infection from June 26, 2009, to March 22, 2010 in England were identified through daily reporting systems and cross-checking of records and were validated by confirmation of influenza infection by laboratory results or death certificates. Clinicians responsible for each individual child provided detailed information about past medical history, presentation, and clinical course of the acute illness. Case estimates of influenza A H1N1 were obtained from the Health Protection Agency. The primary outcome measures were population mortality rates and case-fatality rates.
70 paediatric deaths related to pandemic influenza A H1N1 were reported. Childhood mortality rate was 6 per million population. The rate was highest for children aged less than 1 year. Mortality rates were higher for Bangladeshi children (47 deaths per million population [95% CI 17-103]) and Pakistani children (36 deaths per million population [18-64]) than for white British children (4 deaths per million [3-6]). 15 (21%) children who died were previously healthy; 45 (64%) had severe pre-existing disorders. The highest age-standardised mortality rate for a pre-existing disorder was for chronic neurological disease (1536 per million population). 19 (27%) deaths occurred before inpatient admission. Children in this subgroup were significantly more likely to have been healthy or had only mild pre-existing disorders than those who died after admission (p=0·0109). Overall, 45 (64%) children had received oseltamivir: seven within 48 h of symptom onset.
Vaccination priority should be for children at increased risk of severe illness or death from influenza. This group might include those with specified pre-existing disorders and those in some ethnic minority groups. Early pre-hospital supportive and therapeutic care is also important.
Department of Health, UK.
年轻人(0-18 岁)受到大流行性甲型 H1N1 流感的影响不成比例。我们旨在分析儿科死亡率,以为未来流感季节和大流行提供临床和公共卫生政策信息。
通过日常报告系统以及记录的交叉核对,确定了 2009 年 6 月 26 日至 2010 年 3 月 22 日期间与大流行性甲型 H1N1 感染相关的所有儿科死亡病例,并通过实验室结果或死亡证明确认流感感染对其进行了验证。负责每个孩子的临床医生提供了有关既往病史,表现和急性疾病临床过程的详细信息。甲型 H1N1 流感的病例估计数是从英国卫生保护局获得的。主要结局指标是人群死亡率和病死率。
报告了 70 例与大流行性甲型 H1N1 相关的儿科死亡。儿童死亡率为每百万人口 6 人。年龄小于 1 岁的儿童死亡率最高。孟加拉国儿童的死亡率(每百万人口 47 例死亡[95%CI 17-103])和巴基斯坦儿童(每百万人口 36 例死亡[18-64])高于英国白人儿童(每百万人口 4 例死亡[3-6])。死亡的 15 名(21%)儿童以前身体健康;45 名(64%)患有严重的先前存在的疾病。先前存在的疾病的标准化死亡率最高的是慢性神经疾病(每百万人口 1536 例)。19 例(27%)死亡发生在入院之前。与入院后死亡的儿童相比,该亚组的儿童明显更有可能以前身体健康或仅患有轻度先前存在的疾病(p=0·0109)。总体而言,有 45 名(64%)儿童接受了奥司他韦治疗:7 名儿童在症状发作后 48 小时内接受了治疗。
疫苗接种的重点应针对那些有患流感严重疾病或死亡风险增加的儿童。该人群可能包括有特定的先前存在的疾病和某些少数族裔群体的儿童。早期的医院前支持和治疗也很重要。
英国卫生部。